MedPath
TGA Approval

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack (377572)

377572

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack

Pfizer Australia Pty Ltd

January 20, 2022

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/ab0c3e9b9c7ef8e2eef7f1a85c76c33f.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/bcf4457b8d23b5ccd4553d82df53821b.pdf

Active Ingredients

nirmatrelvir

ritonavir

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PAXLOVID nirmatrelvir 150 mg tablet and ritonavir 100 mg tablet blister composite pack (377572) - TGA 批准文号 | MedPath